Ignite Creation Date:
2025-12-25 @ 3:32 AM
Ignite Modification Date:
2026-03-12 @ 5:54 PM
Study NCT ID:
NCT04103905
Status:
COMPLETED
Last Update Posted:
2025-05-18
First Post:
2019-09-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of MIL62 in Treatment of CD20 Positive B-cell Lymphomas
Sponsor:
Beijing Mabworks Biotech Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-02-10
Start Date Type:
ACTUAL
Primary Completion Date:
2019-05-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-05-29
Completion Date Type:
ACTUAL
First Submit Date:
2019-09-18
First Submit QC Date:
None
Study First Post Date:
2019-09-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-14
Last Update Post Date:
2025-05-18
Last Update Post Date Type:
ACTUAL